Therapeutic vaccines
Nykode develops DNA-based vaccines and other immune therapies for cancer and infectious diseases. The company designs the drug candidates, runs preclinical and clinical studies, and advances them toward approval.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Nykode Therapeutics is a biotechnology company that develops DNA-based vaccines and immunotherapy candidates for cancer and infectious diseases. Its main work is to design vaccine programs that train the immune system to recognize specific targets, then move those candidates through research and clinical testing. The company is not a drug seller in the usual sense; it is building a pipeline of experimental medicines around its core vaccine technology.
The company’s customers are mainly large pharmaceutical partners, research collaborators, and eventually patients if its products win regulatory approval. Today it makes money mostly through collaboration and licensing deals, research funding from partners, and other biotech-style partnership payments tied to its technology and development programs. If its candidates succeed, future revenue would also come from product sales or royalties.
What makes Nykode different is that it sits earlier in the drug value chain than a traditional drugmaker. Instead of manufacturing a broad portfolio of approved medicines, it focuses on creating a platform that can be used to build multiple vaccine candidates from the same underlying technology. That gives it a business model centered on scientific development, partnerships, and long timelines to reach the market.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more